Abingdon Health (LON:ABDX) Issues Quarterly Earnings Results

Abingdon Health (LON:ABDX) announced its quarterly earnings data on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Stock Performance

ABDX opened at GBX 8.50 on Wednesday. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. Abingdon Health has a 52-week low of GBX 5.50 and a 52-week high of GBX 13. The firm has a market cap of £21.48 million, a P/E ratio of -10.49 and a beta of 0.13. The business’s fifty day moving average is GBX 10.74 and its 200-day moving average is GBX 10.52.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.